Aptevo Therapeutics Inc.

US$1.24As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:APVOHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (80.73%)
Div yield —
ROE (420.34%)
Biotechnology
Beta (5Y) 1.63
PE TTM —
TSR TTM (95.56%)
Mkt cap US$3.305M
ROIC (154.28%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.44
15.99%
(31.38%)
Hold 1|3|4|11|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
0.52%
11.28%
17.06%
10.99%
Revenue$M
0.253
0.255
0.263
0.257
2.75%
1.59%
4.20%
2.33%
Peers (US$3.305M)
Cap (US$)
PE
3.410M
—
Capital
TTM
5Y
10Y
Leveragex
2.654
0.289
0.273
EBIT/Intx
1.084
0.485
0.428
Own earn%
(17.68)
(85.67)
(78.64)
Sh yield%
19.61
69.49
58.51
Owners
Insiders/Inst%
4.69
65.19
Short interest%
4.40
SBC / revenue%
3.09
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
13–21
$1 testx
—
Incr. ROIC%
16